News & Analysis on Clinical Trial Services & Contract Research And Development
Intelsius, formerly DGP Group, has introduced Orcatherm to address the increasing pharma industry need for temperature-controlled packaging and regulatory compliant sample transport solutions.
Abbott Laboratories says it will shed manufacturing jobs as part integration of the pharmaceutical business it bought from Solvay earlier this year.
The US FDA’s risk evaluation mitigation strategy (REMS) can be a challenge for pharmaceutical companies unfamiliar with the process according to PPD’s executive director of risk management Frank Gallo.
IDT Biologika unveils plans to expand viral vaccine contract manufacturing operations and says global capacity failing to keep pace with resurgence in drug industry demand.
Worrying times lie ahead for Pfizer’s advertiser, Aegis Group’s Carat, as the drug giant has decided to review its $1.3bn media account, as the firm is speculated to be slashing its outgoings.